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Menadione (MQ), a quinone used with cancer chemotherapeutic agents, causes cytotoxicity to endothelial cells (EC). Previous studies
have suggested that MQ induces an oxidative stress and dysfunction in EC by either increasing hydrogen peroxide (H2O2) production or
depleting intracellular glutathione (GSH), the main intracellular antioxidant. Since a primary function of EC is to form a barrier to fluid
movement into tissues, protecting organs from edema formation and dysfunction, our aim was to see if MQ would cause a barrier dysfunction
and to ascertain the mechanism. Using diffusional permeability to fluorescein isothiocyanate-labeled bovine serum albumin (FITC–BSA) as
a measure of barrier function, we found that 15 AMMQ incubated with a bovine pulmonary artery EC (BPAEC) monolayer for 4 h produced
a profound barrier failure (f 7-fold increase in permeability) with a parallel fall in glutathione, almost to depletion. These two events were
highly correlated. Immunofluorescent imaging showed formation of paracellular holes consistent with a loss or rearrangement of cell–cell
and cell–matrix adhesion molecules. H2O2 (100 AM), a concentration which gave about the same increase in permeability as MQ, only
slightly decreased GSH concentration. Antioxidants, such as catalase (CAT) and dimethylthiourea (DMTU), which were able to block the
H2O2-induced changes, had no effect on the MQ-induced permeability and GSH changes, suggesting that H2O2 was not involved in MQ-
induced effects. MQ caused a severe EC cytotoxicity as judged by lactate dehydrogenase (LDH) leakage from the EC, whereas H2O2 caused
only a minor increase. Also, MQ profoundly inhibited the activities of glucose-6-phosphate dehydrogenase (G6PDH) and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), key thiol enzymes involved in glutathione and ATP metabolism, whereas H2O2 produced only a slight
decrease in these activities. We conclude that the cytotoxicity of MQ and resulting barrier dysfunction correlate with GSH depletion and
inactivation of key metabolic enzymes, compromising antioxidant defenses, rather than being consistent with H2O2-mediated oxidative
stress.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Oxidative stress; Vascular permeability; Endothelial monolayer; Menadione; Glutathione; Hydrogen peroxide; Antioxidant0167-4889/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserved.
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Abbreviations: A, Membrane surface area; DA, Change in absorbance; ATP, Adenosine triphosphate; BPA, Bovine pulmonary artery; BSA, bovine serum
albumin; BSO, buthionine sulfoximine; CAT, catalase; CDNB, 1-chloro-2,4-dinitrobenzene; DMEM, Dulbeccos modified Eagle medium; EC, endothelial
cell(s); DMTU, dimethylthiourea; FITC, fluorescein isothiocyanate; G6P, glucose-6-phosphate; G6PDH, glucose-6-phosphate dehydrogenase; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; GSH, glutathione; GSSG, glutathione disulfide; H2O2, hydrogen peroxide; HEPES, N-[2-hydroxy-ethyl]-
piperazine-NV-[2-ethanesulfonic acid]; HOCl, hypochlorous acid; HUV, human umbilical vein; LDH, lactate dehydrogenase; MEM, minimum essential
medium; MQ, menadione; NAC, N-acetylcysteine; NAD, nicotinamide adenine dinucleotide; NADH, nicotinamide adenine dinucleotide (reduced); NADP,
nicotinamide adenine dinucleotide phosphate; P, permeability; R, ratio of fluorescence in bottom to top wells; ROS, reactive oxygen species; SOD, superoxide
dismutase; t, time; TRITC, tetramethyl rhodamine isothiocyanate; TW, transwell(s); Vb, volume in bottom well; Vt, volume in top well
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W.C. McAmis et al. / Biochimica et Biophysica Acta 1641 (2003) 43–53441. Introduction be depleted by its conjugation with MQ and it is known thatCancer chemotherapeutic agents inhibit cancer-cell pro-
liferation, but may also cause damage to these cells and
normal cells by inducing oxidative stress [1], a condition
characterized by a preponderance of prooxidants over anti-
oxidants [2]. Endothelial cells (EC), in particular, are very
sensitive to oxidative stress [3]. Since chemotherapeutic
agents are introduced into the vascular system at high
concentrations, it is not unexpected that toxicity of vascular
endothelium is the result [4]. This toxicity may be due to
apoptosis (programmed cell death) and other EC dysfunc-
tion as has been shown with cells in culture [5,6]. Also,
chemotherapy-induced dysfunction of large blood vessels
has been seen in tissue and organ models [7,8].
A primary function of vascular endothelium is to form a
barrier to movement of inflammatory cells, protein, solutes
and water between blood and tissues. When this barrier is
disrupted, there is increased transport of this material across
the endothelium and into the tissues, leading to inflamma-
tion, edema and subsequent organ dysfunction. This barrier
disruption may be due to inflammatory mediator-induced
cytoskeletal changes, which may be transient, or to irrever-
sible loss or rearrangement of EC adhesion molecules
caused by cytotoxicity [9].
There is substantial evidence that oxidative stress causes
EC barrier failure [3]. Studies with chemotherapeutic agents
have shown that they cause increases in permeability of
human umbilical vein EC monolayers [10] of human
pulmonary epithelia [11] and development of edema in a
number of animal models [12,13] and in humans [14,15].
However, it is not known if the permeability changes caused
by these agents are related to oxidative stress.
Quinones are a class of agents that can produce cellular
oxidative stress. Many of these agents have anti-tumor
activity; doxorubicin is a prime example [1]. One of the
simplest quinones is menadione (2-methyl-1,4-napthaqui-
none or vitamin K3). Menadione (MQ) has been used in
conjunction with cancer chemotherapeutic agents [16] to
treat various cancers. MQ has been widely studied in EC-
monolayer preparations as a model for assessing the cellular
effects of oxidative stress [17,19], including induction of
apoptosis [18]. Kossenjans et al. [17] have proposed that
MQ causes EC cytotoxicity by stimulating production of
reactive oxygen species (ROS) by redox cycling. By this
mechanism, one electron reduction of O2 by the semi-
quinone form of MQ produces superoxide, which dismu-
tates either spontaneously or is catalyzed by superoxide
dismutase (SOD) to form hydrogen peroxide (H2O2). H2O2
then participates in the Fenton reactions, generating hy-
droxyl radicals. Thus, MQ is proposed to initiate a cascade
of ROS formation which leads to cell injury and death.
Alternatively, Shi et al. [19] have proposed that MQ-
induced EC cytotoxicity is correlated with depletion of
glutathione (GSH), a major thiol antioxidant in cells, as
well as a loss of ATP. These authors suggest that GSH mightGSH depletion precedes release of cytoplasmic enzymes
[20], a sign of cytotoxicity. However, cytotoxicity may also
be produced by MQ arylation of proteins [21] and oxidant-
stress-induced protein modifications [22], thereby altering
the activity of key thiol enzymes involved in glutathione and
ATP metabolism in EC, e.g., glucose-6-phosphate dehydro-
genase (G6PDH) and glyceraldehyde-3-phosphate dehydro-
genase (GAPDH), respectively.
Proteins in cellular and subcellular membranes and in
the cytoskeleton may also be altered by quinones, thus
leading to permeability changes. MQ has been shown to
induce permeability increases in erythrocytes, and mito-
chondria [20] and surface bleb formation in a number of
cell types [23]. Hence, this study tests the hypothesis in a
bovine pulmonary artery EC (BPAEC) monolayer system
that MQ causes EC barrier failure (increase in permeability)
due to cell cytotoxicity, induced by modification of intra-
cellular protein and non-protein thiols instead of H2O2
production.2. Materials and methods
All chemicals were obtained from Sigma Chemical Co.,
St. Louis, MO, unless otherwise indicated.
2.1. Cell culture and barrier-function measurement
Procedures for cell culture were as described previously
[24]. Bovine pulmonary artery endothelial cells (BPAEC)
(passages 6–13) were grown in Dulbecco’s modified Eagle
medium (DMEM, Cellgro) with 10% fetal bovine serum
(FBS, Cellgro) to confluence (3–5 days) on Corning–
Costar Transwells (TW, 0.33 cm2 surface area) inserted into
12 wells of a 24-well plate or on 100-mm dishes (Sarstedt).
The monolayers were washed with minimum essential
medium (MEM), containing 15 mM N-[2-hydroxy-ethyl]-
piperazine-NV-[2-ethanesulfonic acid] (HEPES)–MEM, and
then incubated in HEPES–MEM along with the various
agents used in this study for a 4-h time period. Top and
bottom wells contained 100 and 600 Al of these solutions,
respectively. Typically, two TWs were used for each con-
dition. Hence, there were six conditions per plate of 12 TWs
with one to three plates per experiment. Next, these sol-
utions were removed from contact with the cells and
monolayer barrier function determined by adding 100 Al
of FITC (Molecular Probes, Eugene, OR)–bovine serum
albumin (BSA) in HEPES–MEM, to each top well and 600
Al of the HEPES–MEM to the corresponding bottom wells
in another 24-well plate. The volumes used avoided any
convective transport due to hydrostatic pressure gradients
between the two wells. At time zero, the top wells were
rapidly transferred to the other plate’s bottom wells. At 1.5
h, the diffusional transport was stopped by rapidly trans-
ferring the top wells back to the original plate. Aliquots (10
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another plate and 590 Al of the HEPES–MEM added to
each of these wells to total 600 Al. Fluorescence in the 24-
well plates was measured (excitation at 485 nm; emission at
535 nm) in a Tecan SPECTRAfluor microplate reader.
P ¼ Vb  Vt








FITC–BSA diffusional permeability (P), a measure of
barrier function, was determined in each TW from the
measured fluorescence concentrations and the accompany-
ing equation derived from Fick’s law of diffusion [25],
where t is time after tracer addition, A is the surface area of
the membrane, Vb and Vt are the volumes of fluid in the
bottom and top wells, respectively, and R is the ratio of the
fluorescence measurements in the bottom to top wells
corrected for dilution. In this calculation, the permeability
of the TW membrane support is included. Correction for the
effect of this barrier in series with the monolayer would
yield monolayer permeability values larger than those meas-
ured [26], particularly for the higher measured values (see
Discussion). Albumin permeability was determined because
it is the principle plasma protein. Its size is sufficiently large
that it is normally highly restricted by the endothelial
barrier. Hence, its permeability value is very sensitive to
the opening of large paracellular holes. Permeability values
reported are the average of those measured in two TWs.
Replicate measurements typically varied by < 10%.
2.2. Glutathione assay
Cellular GSH content was determined by the enzymatic
recycling process of Griffith [27]. Glutathione disulfide
(GSSG) was determined using the same method except that
4-vinylpyridine was used to derivatize the GSH present
[28]. For each experimental condition, one dish was used for
total glutathione (GSH+ 2 x GSSG) and the contents of
three dishes were pooled for GSSG. The cellular contents of
GSH and GSSG were normalized to the amount of protein
(Lowry) in the dish, typically 1–1.5 mg.
2.3. Enzyme assays
G6PDH activity was measured by the rate of reduction of
nicotinamide adenine dinucleotide phosphate (NADP) by
glucose-6-phosphate (G6P). Briefly, cells were scraped off
100-mm dishes and centrifuged. The supernatant was dis-
carded, 1 ml of assay buffer (55 mM Tris–HCl, pH 7.8 with
3.3 mM MgCl2) added to the pellet and the mixture
sonicated gently (30 s, medium power) with a HeatSys-
tems—Ultrasonics Inc. model 375 Sonicator. The sonicates
were then centrifuged for 20 min in a Beckman L5-50B
ultracentrifuge at 40,000 rpm. Aliquots (100 Al) of the cell
sonicates, 600 Al of the assay buffer, 25 Al of 6 mM NADPand 25 Al of 100 mM G6P were added to wells of a 48-well
plate (Falcon) and the change in absorbance (DA) monitored
(340 nm) for 6 min in the microplate reader at 30 jC. The
enzyme activity was determined from the slope of DA vs. t
as corrected for a substrate-free blank and normalized to the
mg protein/dish from the protein assay.
The GAPDH assay was similar to that above for G6PDH
except that the assay buffer added to each well consisted of
668 Al of 0.015M sodium pyrophosphate buffer, pH 8.5
containing 0.03 M sodium arsenate, 25 Al of 7.5 mM NAD,
25 Al of 0.015 M DL-glyceraldehyde-3-phosphate and 25 Al
of 0.1 M dithiothreitol. The assay was initiated by adding 7
Al of cell supernatant to each well. The analysis procedure
was basically the same as above, except that the reaction
was at 25 jC.
To assess cell cytotoxicity, lactate dehydrogenase (LDH)
leakage was determined in the extracellular cell-culture
medium using an assay by Sigma which determines the rate
at which the substrate, pyruvate, is reduced to lactate. The
reduction is coupled with the oxidation of nicotinamide
adenine dinucleotide (reduced form, NADH) to NAD,
which is followed spectrophotometrically as a rate of
absorbance decrease at 340 nm. Samples (400 Al) of media
were removed from the cell-culture dishes and added to 2.5
ml of 0.1 M potassium phosphate buffer adjusted to pH 7.5.
The resulting mixture was incubated at room temperature
for f 5 min. Then, 100 Al of a 22.7 mM sodium pyruvate
solution in 0.1 M phosphate buffer was added to the tube,
the contents mixed and the rate of absorbance decrease over
2.5 min determined with the microplate reader. The units
(U) of enzyme in each cell culture sample were determined
by assaying a 40-Al sample of a 1:5500 dilution of a
standard LDH enzyme (Calbiochem). The sample values
were converted to U/mg protein by multiplying by the
dilution factor (dish volume/sample volume) and dividing
by the amount of protein in the dish.
2.4. Labeling of cell structures
To determine how the cytoskeleton and/or EC adhesion
molecules were affected by MQ and H2O2, BPAECs grown
to 4 days post-confluence in eight-well slides were treated
and stained as previously described [29]. Primary monoclo-
nal antibodies to a-catenin (1:100 dilution, Zymed Labora-
tories Inc.) were used to detect the adherens junctions and
mouse anti-paxillin IgG (1:200 dilution, Chemicon, Teme-
cula, CA) was used to detect focal adhesions to the extra-
cellular matrix. After washing, secondary goat tetramethyl
rhodamine isothiocyanate (TRITC) or Cy5-labeled anti-rab-
bit IgG (1:25 dilution) and goat-Cy5 anti-mouse IgG (1:25
dilution; Jackson Immunoresearch Labs Inc., Westgrove,
PA) were used to label each primary IgG. Alexa 488-
phalloidin (Molecular Probes) was used to label F-actin.
The slide was covered with Vectashield mounting medium
(Vector Laboratories, Inc., Burlingame, CA), a #1 coverslip
was applied and the edges were sealed with nail polish.
Fig. 2. FITC–BSA permeability changes in response to varying
concentrations of H2O2 incubated with the cells for 4 h. N = 22 for control
data, N = 17 for 100 AM concentration and N= 2–6 for remainder of data. A
concentration of 100–250 AM gave a maximal response similar to that of
10–15 AM MQ (see Fig. 1).
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The digital imaging microscopic workstation used to
view stained slides was a Nikon E-800 microscope with
an 60 , 1.4 NA oil immersion objective; a PerkinElmer
Wallac UltraVIEW confocal scanner with a 50-mW Kryp-
ton/Argon three-line laser was used to simultaneously
collect Alexa 488, TRITC or Cy5 staining patterns for each
sample. Epifluorescent digital images were collected with
online background-subtraction and shading correction at 12-
bit depth using a Photometrics (Tucson, AZ) PXL CCD
camera containing a Kodak 1400 chip that was thermostati-
cally cooled to  25 jC to reduce dark current noise and
controlled with MetaMorph software (Version 4.0 Universal
Imaging Corporation). MetaMorph was used to identify
regions of colocalization by color encoding the separate
immunofluorescent images of each cell.
2.6. Antioxidants and other agents used
MQ was used in concentrations up to 15 AM, which was
sufficient to produce profound endothelial barrier failure
(Fig. 1). H2O2 was used in concentrations up to 250 AM
which produced a similar barrier failure (Fig. 2). Catalase
(CAT) was used at 100 U/ml [30] and at 1000 U/ml to block
H2O2 production and 60 U/ml superoxide dismutase (SOD),
[30] was used to see if superoxide production caused any of
W.C. McAmis et al. / Biochimica e46Fig. 1. FITC–BSA permeability of BPAEC monolayers for a 4-h
incubation with varying concentrations of MQ. The filled circles show
mean values for N= 8 measurements at various concentrations with SE bars
indicated. N= 37 for control monolayers (0 AM), N= 33 for the 15 AM
concentration and N = 2–8 for the other concentrations. Concentrations
<f 4 AM are not significantly different from control whereas concen-
trations >f 10 AM give maximal responses. The solid line is a sigmoidal
fit to these data.the cell damage seen. Dimethylthiourea (DMTU), which is a
scavenger of hydroxyl radicals [31]and H2O2 [32] and also
has metal chelating activity [33], was used at 10 mM. All
inhibitors were preincubated with the cells for 30–60 min
prior to the application of the MQ or H2O2.
In addition, 1-chloro-2,4-dinitrobenzene (CDNB) was
used for 4 h at concentrations up to 20 AM to lower
intracellular GSH concentration. The reason was to see if
an agent whose main characteristic was GSH conjugation
[34], rather than redox recycling, could induce a perme-
ability increase. Also, buthionine sulfoximine (BSO), an
inhibitor of GSH synthesis, was used at 2 and 20 mM
concentrations [19].
2.7. Statistics and data analysis
Data given in the text and graphs are meanF S.E.
Permeability values at each concentration of an agent
were assessed for statistical significance by comparison
with appropriate control data using the analysis of var-
iance (ANOVA) technique [35]. Paired data were used
when appropriate. The same approach was used to deter-
mine statistical significance for the glutathione and
enzyme activity data. Significance was accepted at the
P < 0.05 level. ANOVA statistical comparisons were per-
formed with the InStat computer program (GraphPad, San
Diego, CA). Sigma Plot (SPSS Inc., Chicago, IL) was
used to determine correlations between variables, to esti-
mate linear regression parameters and to fit sigmoidal
curves to data.
Fig. 4. The effect of MQ on intracellular GSH and GSSG concentrations.
N = 5 for each MQ concentration, except the control and 15 AM
concentrations, where N = 11. As seen, MQ concentrations >f 3 AM
significantly reduced GSH. The cells were almost depleted of GSH at 15
AM concentration. MQ also lowered GSSG concentration as shown by data
from the same experiments where GSH was measured. The ratio of GSSG
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3.1. Effect of MQ and H2O2 on barrier function (BSA
permeability)
Fig. 1 shows that a 4-h exposure of EC monolayers to
MQ increased FITC–BSA permeability in a concentration-
dependent manner. MQ, at concentrations >f 10 AM,
produced maximal responses of about seven to eight times
the control, whereas concentrations <f 4 AM produced no
significant effects. These concentrations are in the range of
those used in clinical studies [36].
To test the hypothesis that MQ-induced H2O2 production
was responsible for the endothelial dysfunction [17], we
first had to establish the concentration of H2O2 that would
produce an effect similar to that of MQ. As seen in Fig. 2,
100 to 250 AM H2O2 induced maximal effects of about the
same degree of barrier dysfunction within the same time
period (4 h) as the higher concentrations of MQ (see Fig.
1). Concentrations of 15 AM MQ and 100 AM H2O2 were
used in subsequent experiments to compare the ability of
various agents to block these responses. This approach
approximated the effect of intracellular H2O2 production
because H2O2 is able to diffuse rapidly across cell mem-
branes [2].Fig. 3. Effect of various antioxidant agents on MQ- and H2O2-induced
FITC–BSA permeability increases. MQ (15 AM) and H2O2 (100 AM)
produced large increases in permeability (light gray and dark gray hatched
bars, respectively) from control levels (black bar); N = 10 and 14,
respectively. CAT (100 U/ml) and DMTU (5 mM) were able to totally
block the increase induced by H2O2 (*P>0.05 relative to values with
inhibiting agent alone, black bars); N = 5. SOD (60 U/ml) had no effect;
N= 3. Only NAC (250 AM) inhibited the MQ-induced increase (**P>0.05
relative to NAC alone, black bar); N = 3. However, NAC only partially
blocked the increase induced by H2O2 (***P< 0.05 relative to both the
H2O2 control and the NAC alone control, black bars); N= 4.
to GSH did not change significantly (data not shown). MQ concen-
trations >10 AM decreased total glutathione (GSH+ 2 GSSG) to almost
negligible levels.Fig. 3 shows the effect of a number of antioxidant agents
on barrier dysfunction caused by a 4-h incubation of EC
with H2O2 or MQ. CAT and DMTU completely inhibited
the H2O2-induced increases in permeability, but these agents
had no effect on the action of MQ. A 10-fold higher
concentration of CAT increased baseline permeability sig-
nificantly, but had no effect on the MQ-induced increases
(data not shown). NAC blocked the effects of both MQ and
H2O2, whereas SOD had no effect on either system.
Because of the lack of effect of CAT, SOD or DTMU, these
results suggest that increased production of ROS may not be
directly involved in MQ-induced toxicity. The effect of
NAC may be by other mechanisms (see Discussion).
3.2. Effect of MQ and H2O2 on intracellular glutathione
Because oxidative stress may be induced by either
increased production of ROS and/or depletion of antioxidant
defenses, we measured the effect of MQ on intracellular
GSH and GSSG concentrations in separate experiments
from the permeability studies. As shown in Fig. 4, treatment
of EC with MQ significantly lowered intracellular GSH
levels; at 10–15 AM MQ, GSH was reduced by >90%.
GSSG decreased similarly with increasing MQ concentra-
tion. The GSH to GSSG ratio apparently fell, going from
26.6F 6 (S.E.) to 10.8F 2.3 for control cells or cells
exposed to 15 AM MQ, respectively, but this change was
Fig. 6. Effect of MQ and H2O2 as in Fig. 3 on sulfhydryl enzyme activities.
The data are normalized to control values. As seen, MQ induced an f 80%
reduction in G6PDH and GAPDH activities; *P < 0.001, N= 9. In contrast,
H2O2 produced a much smaller, but significant, decrease; **P < 0.05, N= 9.
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out a change in GSH to GSSG ratio, suggests that this
depletion, rather than increased ROS production due to
redox recycling, may explain the cytotoxicity induced by
MQ and other quinones.
As seen in Fig. 5, 15 AM MQ produced a dramatic
decrease in GSH. In contrast, 100 AM H2O2, the concen-
tration that produced a permeability increase comparable to
MQ, produced only a small, albeit statistically significant,
decrease in GSH. DMTU inhibited the small depletion of
GSH induced by H2O2, but was ineffective against MQ,
suggesting that MQ toxicity was not mediated by produc-
tion of H2O2. NAC inhibited GSH depletion caused by both
agents, implicating thiols in the mechanism of action of both
H2O2 and MQ.
3.3. Effect of MQ and H2O2 on enzyme activities
Fig. 6 shows the effects of a 4-h incubation of 15 AMMQ
and 100 AM H2O2 on EC G6PDH and GAPDH activities.
MQ decreased the activities of both enzymes by f 80%
while, despite comparable affects on barrier function, H2O2
had only a marginal effect on these enzyme activities. These
results indicate that oxidative stress can modify key sulf-
hydryl enzymes, but they also argue strongly that the
mechanisms by which MQ and H2O2 exert their actions on
EC monolayers are different.
Fig. 7 shows the changes in LDH leakage under the same
conditions as for Fig. 6. As seen, MQ caused a large,Fig. 5. Effect of antioxidant agents on intracellular glutathione changes
induced by MQ and H2O2. As seen, under the same conditions as the data
in Fig. 3, H2O2 induced a small, but significant (*P< 0.05) decrease in
glutathione relative to control; N = 6. In contrast, MQ virtually depleted
(**P< 0.001 relative to control, light-gray bars) glutathione (data from Fig.
4). DMTU restored glutathione levels reduced by H2O2 (N= 7), whereas
DMTU had no effect on MQ-induced glutathione depletion. NAC reversed
the effects of both H2O2 and MQ (N= 5 and 6, respectively).statistically significant, increase in leakage. In contrast,
H2O2 did not produce a statistically significant effect.
Hence, extracellular LDH leakage is not a good predictor
of barrier dysfunction.Fig. 7. Extracellular LDH accumulation produced by MQ and H2O2 as in
Fig. 3. The values shown are the increases from control values of
0.43F 0.07 U/mg protein. As seen, MQ induced a significant increase
(*P< 0.01) of LDH leakage, whereas H2O2 produced no significant
increase.
Fig. 9. Correlation between the permeability increase and GSH decrease (4-
h incubation) caused by CDNB, a drug which depletes intracellular GSH.
Each set of data was measured in different experiments. The data are
normalized as in Fig. 8. The high degree of correlation (r2 = 0.94) and a
slope not significantly different from  1.0 are supportive of a role of
glutathione in inducing a barrier dysfunction.
et Biophysica Acta 1641 (2003) 43–53 493.4. Relation between MQ-induced glutathione depletion
and barrier dysfunction
To explore the possibility that barrier dysfunction is
induced by MQ-induced glutathione depletion, we plotted
the MQ-induced changes in permeability and glutathione
concentrations (Figs. 1 and 4) against each other (Fig. 8).
There was an excellent correlation between the two varia-
bles, with a slope not significantly different from  1.0.
This result supports the hypothesis that a depletion of
glutathione modulates barrier function.
3.5. Effect of glutathione depletion on barrier function
We investigated the effects of other drugs that specifi-
cally lower glutathione levels in cells to determine whether
purposeful manipulation of this variable could induce bar-
rier dysfunction. BSO, which inhibits g-glutamylcysteine
synthetase, an enzyme required for GSH synthesis, has been
used to lower glutathione levels [37]. However, we found
that BSO concentrations as high as 20 mM failed to produce
either an increase in permeability or a decrease in gluta-
thione concentration (data not shown) during the 4-h incu-
bation period used in the experiments. In earlier work,
however, we showed [24] that 48 h of incubation with >1
mM BSO produced significant increases in permeability and
concomitant decreases in glutathione concentration. These
results were consistent with the hypothesis that thiol deple-
tion could lead to barrier failure. We then tried CDNB,
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Figs. 1 and 4. Each set of data was measured in different experiments. Both
variables were normalized to their maximum values and permeability was
corrected for its minimum value during control conditions. N = 10
experiments for controls and from 3–9 for the other data points. These
data are highly correlated (r2 = 0.96), with a slope not significantly different
from  1.0 ( P < 0.05). This result is consistent with the hypothesis that
glutathione depletion leads to a barrier dysfunction.which conjugates to GSH in the cell, but does not redox
recycle [34]. A 4-h incubation with CDNB produced
increases in permeability and decreases in glutathione as
shown in Fig. 9. The correlation between these two varia-
bles was similar to that induced by MQ (see Fig. 8).
To determine if the barrier dysfunction induced by
CDNB could be due to inhibition of GAPDH and subse-
quent ATP depletion, or inhibition of G6PDH, we measured
the effect on the enzymes of a 4-h incubation of the EC with
the same concentrations of CDNB used to deplete gluta-
thione (Table 1). As seen, there was no significant effect on
GAPDH, however, the highest concentration of CDNB
induced some inhibition of G6PDH activity, but not to the
extent induced by MQ (see Fig. 6).Table 1
Effect of CDNB on GAPDH and G6PDH activities
CDNB (AM) 0 1 3 5 10 20
Abs/min/mg protein GAPDHa
Mean* 1.60 1.40 1.54 1.49 1.38 1.20
S.E. 0.12 0.09 0.10 0.10 0.10 0.08
Abs/min/mg protein G6PDHb
Mean** 0.193 0.168 0.181 0.163 0.170 0.140**
S.E. 0.055 0.042 0.048 0.039 0.046 0.032
a N = 7 experiments.
b N= 5 experiments.
*The main effect of GAPDH was not significant ( P>0.05, by repeated
measures ANOVA).
**The main effect of G6PDH was significant ( P< 0.05) and the effect
of the 20 AM concentration was significantly different from that of the
control.
t Biophysica Acta 1641 (2003) 43–533.6. Endothelial morphometry
Using immunofluorescent imaging techniques, we inves-
tigated the mechanism by which MQ causes such a pro-
W.C. McAmis et al. / Biochimica e50found endothelial barrier failure. Fig. 10a displays a number
of control EC shown outlined by the blue staining, a-
catenin, cell–cell adhesion molecules (double arrows).
Evident are a few F-actin stress fibers (green staining,
arrow) running the length of each cell and distinct pax-
illin-containing focal adhesions (red, arrowhead) connecting
the stress fibers to the underlying extracellular matrix. MQ-
treated cells (Fig. 10b) became rounded and there were large
paracellular holes (*) characteristic of a loss or rearrange-
ment of cell–cell and focal adhesions. There was also a
large decline in F-actin stress fibers in general and in those
linked to paxillin-containing focal adhesions. The a-catenin
is only prominent at the junctions of the few cells that are
still in contact. H2O2-treated cells (Fig. 10c) were also
rounded and there were large paracellular holes character-
istic of a barrier failure. However, in contrast to the effects
of MQ, many stress fibers were still evident. Hence, there
are differences in the way that MQ and H2O2 affect cell
morphology.4. Discussion
The principal findings in this study are: (1) MQ induces
an EC barrier dysfunction which cannot be inhibited by
antioxidants; (2) MQ induces an EC glutathione depletion
correlated with the barrier dysfunction; (3) MQ inhibits key
thiol enzymes involved with glutathione and ATP metabo-
lism; (4) H2O2 can produce a barrier dysfunction equivalent
to that of MQ, but with only minor glutathione depletion
and inhibition of thiol-enzyme activities; (5) MQ causes a
large increase in LDH leakage indicating significant cell
damage whereas H2O2, at concentrations producing an
equivalent barrier dysfunction, produces much less damage;
and (6) MQ-induced barrier dysfunction involves a loss or
rearrangement of cell–cell and cell–matrix adhesion mole-
cules. These results are consistent with our hypothesis that
MQ causes EC barrier failure due to cell cytotoxicity, which
is induced by modification of intracellular protein and non-
protein thiols and not by H2O2 production.
Our hypothesis is contrary to that of Kossenjans et al.
[17] who found that DMTU countered the MQ-induced
cytotoxicity in cardiac microvascular EC. We found that
DMTU failed to inhibit either MQ-induced barrier dysfunc-
tion or glutathione depletion in BPAEC monolayers even
though DMTU is a potent scavenger of H2O2 and hydroxylFig. 10. BPAECs were triple labeled for F-actin (green), a-catenin (blue)
and paxillin (red) after 4 h of incubation. Panel a: Control cells with few F-
actin stress fibers (arrow), some paxillin-containing focal adhesions
(arrowhead) and distinct a-catenin-containing cell –cell adhesions (double
arrows). Panel b: 15 AMMQ treatment produced large paracellular holes (*)
in association with a decline in F-actin stress fibers linked to paxillin-
containing focal adhesions and a loss or rearrangement of a-catenin at cell –
cell adhesions. Panel c: 100 AM H2O2 treatment caused paracellular holes
similar to MQ, but the F-actin stress fibers were much more numerous.
Bar = 5 Am.
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reactions. Similarly, CAT did not inhibit the MQ-induced
barrier dysfunction which would be expected if H2O2 was
the cause. However, in our experiments, CAT could only
scavenge H2O2 present extracellularly, which leaves the
possibility that H2O2 generated inside the cell still could
cause damage. To minimize this possibility, we used very
high concentrations of CAT which should have rapidly
depleted any H2O2 generated because of the high rate of
H2O2 diffusion across cell membranes [2].
Kossenjans et al. [17] used much higher concentrations
of MQ, 100–200 AM, and exposure times up to 10 h
compared to the maximum of 15 AM and 4 h in the present
study. They saw significant LDH release only after 5 h,
which was preventable by DMTU. In contrast, we observed
that cytotoxicity (LDH leakage) and EC barrier dysfunction
occurred at earlier times and at lower, chemotherapeutically
relevant concentrations of MQ. It is possible that increased
ROS production might occur on more prolonged exposure
to higher doses of MQ.
Since MQ-induced ROS production is not directly
responsible for the endothelial dysfunction seen in the
present study, then other mechanisms must be considered.
(1) MQ binds to GSH [38], which would lead to the
glutathione depletion seen in the present study. Since GSH
inhibits the activation of the proinflammatory nuclear factor-
nB [3], GSH depletion could lead to an inflammatory EC
barrier dysfunction. The ability of NAC (GSH precursor) to
block the MQ-induced barrier dysfunction (see Fig. 3) could
be explained by an extracellular arylation with MQ. Chang
et al. [38] showed that the MQ-GSH binding product is
nontoxic in the extracellular medium and that it does not
enter EC. (2) In addition, MQ may act to directly modify
key intracellular enzymes (protein-S-thiolation) involved in
glutathione and ATP metabolism. Lusini et al. [21] have
shown in human erythrocytes that MQ not only forms a
conjugate with GSH, but also with proteins. These effects of
MQ and other quinones were also observed in platelets [39].
There is strong evidence that some of the proteins which
are modified are enzymes involved in glutathione and ATP
metabolism. Ciolino and Levine [22] found that bovine
aortic EC exposed to 75 AM H2O2 and Fe3 + showed rapid
oxidation of proteins preceding loss of cellular ATP and
eventual cell death. The protein oxidation paralleled loss of
activity in G6PDH and GAPDH, key enzymes in glutathione
and ATP metabolism, respectively. Leopold et al. [40] found
that G6PDH deficiency contributes to EC oxidative stress by
depleting the reduced form of nicotinamide adenine dinu-
cleotide phosphate (NADPH), the coenzyme generated by
the pentose-shunt pathway, required for the regeneration of
GSH after it has been oxidized to GSSG to counter oxidant
production. We found similar high degrees of inhibition of
these enzymes by MQ (see Fig. 6), but in contrast, 100 AM
H2O2 produced much less of an inhibition. It is possible that
the Fe3 + is required to produce significant damage by
catalyzing the Fenton reaction. Regardless, it is clear thatthese enzymes are susceptible to modification by a number
of mechanisms.
We found that MQ induced a >80% decrease in G6PDH
activity, which would lead to a large reduction in NADPH
production, and theoretically, an increase in GSSG. How-
ever, in contrast, we actually detected a decrease in both
GSH and GSSG. Pullar et al. [41] found in human umbilical
vein EC (HUVEC) that hypochlorous acid (HOCl) also
caused a depletion of GSH, without a corresponding in-
crease in GSSG, similar to the results of the present study.
Protein-S-thiolation was not a major contributor to the GSH
loss in that study. Rather, the products of the reaction,
mainly glutathione sulfonamide, were mostly exported from
the cell. Similarly, MQ arylation to proteins has been shown
to deplete GSH in erythrocytes without an accompanying
GSSG increase [21].
Glutathione depletion seems to play a key role in pro-
ducing a barrier failure in EC, irregardless of the mechanism
leading to this loss. We found that CDNB produced a
glutathione depletion and barrier failure similar to MQ (see
Fig. 6), but CDNB did not significantly inhibit G6PDH (see
Table 1) except at the highest concentration. However, this
inhibition was much less than that caused by MQ.
The large increases in permeability induced by MQ may
be partly the result of apoptotic and necrotic processes and
some subsequent detachment from the TW membrane (see
below). Warren et al. [18] found that a 1-h incubation of
bovine aortic EC monolayers with 35 AM MQ caused up to
30% of the cells to become apoptotic at 5–7 h later; MQ-
induced depletion of intracellular thiols and ATP [42] may be
the cause. Tian et al. [43] have shown that G6PDH plays a
critical role in cell death. G6PDH inhibitors potentiated
H2O2-induced death of bovine aortic EC, whereas over-
expression of this enzyme provided protection. However, it
may be the resulting glutathione depletion rather than the
reduction in G6PDH activity which triggers apoptosis since
glutathione depletion in neuronal cells precedes the mito-
chondrial impairment which initiates apoptosis [44]. Deple-
tion of ATP also can modulate apoptosis and provide a switch
between apoptosis and necrosis [45]. In another study using
HOCl with HUVEC, Pullar et al. [46] found that GAPDH
was particularly susceptible to oxidation. ATP levels fell on
exposure to HOCl, but only part of this decrease was due to
the GAPDH inactivation. Our results showed that MQ
induced a >70% decrease in GAPDH activity.
The maximum permeability values measured in our study
were limited by the permeability of the TW membrane
(f 3110 6 cm/s). Correction for this effect would
increase the estimated permeability of the cell monolayer;
this effect would be significant for the larger measured
values, likely indicating cell detachment from the TW
membrane as well as the cell rounding seen in Fig. 10.
We did not incorporate this correction in the data reported in
this study because it did not change our principal findings.
We have identified a number of factors in MQ-induced
EC dysfunction. However, exactly how these factors lead to
W.C. McAmis et al. / Biochimica et Biophysica Acta 1641 (2003) 43–5352a barrier dysfunction is still not clear. There is extensive
evidence [3] that oxidative stress results in a change in the
EC cytoskeleton and a loss or rearrangement of EC adhesion
molecules resulting in EC rounding and gap formation. We
found that MQ produced cytoskeletal changes, loss of cell–
cell (a-catenin) and cell–matrix (paxillin) adhesion mole-
cules and resultant large paracellular holes in the BPAEC
monolayers (see Fig. 10). It is probable that some of these
holes are the result of cell detachment from the TW mem-
brane as a result of the loss of adhesion molecules between
cells and to the extracellular matrix. MQ-induced cytoske-
letal changes have been seen before in other cell types [23].
Oxidation of thiol groups in cytoskeletal proteins has been
identified [47] as a possible causative factor, which is
consistent with the thiol modifications found in the present
study. In contrast, in our study, 100 AM H2O2 did not appear
to alter the cytoskeleton at 4 h of incubation (see Fig. 10) nor
cause the glutathione depletion and enzyme inhibition.
However, much higher concentrations of H2O2 have been
shown [48] to cause rapid, but transient, glutathione deple-
tion and membrane blebbing in HUVEC. Hence, both H2O2
and MQ act to cause EC cytotoxicity, but likely over differ-
ent time scales and by different mechanisms.
In summary, our results support the hypothesis that MQ
causes oxidative stress and EC cytotoxicity by altering
intracellular thiols, rather than by stimulating ROS produc-
tion. MQ probably produces its effects both by conjugating
to nonprotein thiols and by inactivating key thiol enzymes,
G6PDH and GAPDH. The resultant fall in GSH, and
probably ATP, triggers cell cytotoxicity, including loss and
rearrangement of cell adhesion molecules and cytoskeletal
changes, resulting in a barrier dysfunction. This dysfunction
caused by quinones, such as doxorubicin, and other cancer
chemotherapeutic agents in vivo could result in edema
formation and organ dysfunction, which explain in part
the toxicity and side effects of many chemotherapeutic
agents.Acknowledgements
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